Agenus | AGEN - PE Price to Earnings


Agenus reported 17.82 in PE Price to Earnings for its fiscal quarter ending in June of 2022.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
CSL 16.16 9.59 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 14.84 2.79 Dec/2025
Intrexon 7.54 221.44 Dec/2021
J&J 23.62 0.86 Dec/2025
Jiangsu Hengrui 62.99 17.04 Sep/2025
Merck 20.56 7.18 Dec/2025
Merck 13.92 5.08 Dec/2025
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Novartis 17.85 2.11 Dec/2025
Novavax 2.01 1.07 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 45.3 5.4 Dec/2025